Classical cadherins control survival through the gp130/Stat3 axis

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1833, Issue 8, 2013, Pages 1947-1959

  Geletu, M ^a   Arulanandam, R ^a,f   Chevalier, S ^b   Saez, B ^c,d   Larue, L ^e   Feracci, H ^b   Raptis, L ^a  

^a QUEEN S UNIVERSITY   (Canada)

^b UNIVERSITÉ DE BORDEAUX   (France)

^c INSTITUTO ARAGONÉS DE CIENCIAS DE LA SALUD   (Spain)

^d UNIVERSITY OF ZARAGOZA   (Spain)

^e Centre National de la Recherche Scientifique   (France)

^f OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

Author keywords

Cadherin; Epithelial cell; Rho GTPase; Signal transduction; Stat3

Indexed keywords

CADHERIN; CADHERIN 11; GLYCOPROTEIN GP 130; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE; NERVE CELL ADHESION MOLECULE; STAT3 PROTEIN; UNCLASSIFIED DRUG; UVOMORULIN;

ANIMAL CELL; ARTICLE; CARCINOMA CELL; CELL CULTURE; CELL DENSITY; CELL GROWTH; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; EPITHELIAL MESENCHYMAL TRANSITION; GENE SILENCING; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; UPREGULATION;

ANIMALS; BALB 3T3 CELLS; CADHERINS; CDC42 GTP-BINDING PROTEIN; CELL ADHESION; CELL DIVISION; CELL LINE, TRANSFORMED; CELL SURVIVAL; CYTOKINE RECEPTOR GP130; EPITHELIAL-MESENCHYMAL TRANSITION; GTP PHOSPHOHYDROLASES; INTERLEUKIN-6; JANUS KINASES; MAP KINASE SIGNALING SYSTEM; MICE; NEUROPEPTIDES; NF-KAPPA B; RAC GTP-BINDING PROTEINS; STAT3 TRANSCRIPTION FACTOR; UP-REGULATION;

EID: 84877832024     PISSN: 01674889     EISSN: 18792596     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2013.03.014     Document Type: Article

References (68)

1. Stemmler M.P. Cadherins in development and cancer. Mol. Biosyst. 2008, 4:835-850.
2. Wheelock M.J., Shintani Y., Maeda M., Fukumoto Y., Johnson K.R. Cadherin switching. J. Cell Sci. 2008, 121:727-735.
3. Takeichi M. Morphogenetic roles of classic cadherins. Curr. Opin. Cell Biol. 1995, 7:619-627.
4. Larue L., Antos C., Butz S., Huber O., Delmas V., Dominis M., Kemler R. A role for cadherins in tissue formation. Development 1996, 122:3185-3194.
5. Patel S.D., Chen C.P., Bahna F., Honig B., Shapiro L. Cadherin-mediated cell-cell adhesion: sticking together as a family. Curr. Opin. Struct. Biol. 2003, 13:690-698.
6. Hulpiau P., van Roy F. Molecular evolution of the cadherin superfamily. Int. J. Biochem. Cell Biol. 2009, 41:349-369.
7. Koch A.W., Pokutta S., Lustig A., Engel J. Calcium binding and homoassociation of E-cadherin domains. Biochemistry 1997, 36:7697-7705.
8. Courjean O., Chevreux G., Perret E., Morel A., Sanglier S., Potier N., Engel J., van Dorsselaer A., Feracci H. Modulation of E-cadherin monomer folding by cooperative binding of calcium ions. Biochemistry 2008, 47:2339-2349.
9. Halbleib J.M., Nelson W.J. Cadherins in development: cell adhesion, sorting, and tissue morphogenesis. Genes Dev. 2006, 20:3199-3214.
10. Nollet F., Kools P., van Roy F. Phylogenetic analysis of the cadherin superfamily allows identification of six major subfamilies besides several solitary members. J. Mol. Biol. 2000, 299:551-572.
11. Chu Y.S., Eder O., Thomas W.A., Simcha I., Pincet F., Ben-Ze'ev A., Perez E., Thiery J.P., Dufour S. Prototypical type I E-cadherin and type II cadherin-7 mediate very distinct adhesiveness through their extracellular domains. J. Biol. Chem. 2006, 281:2901-2910.
12. Pierres A., Feracci H., Delmas V., Benoliel A.M., Thiery J.P., Bongrand P. Experimental study of the interaction range and association rate of surface-attached cadherin 11. Proc. Natl. Acad. Sci. U. S. A. 1998, 95:9256-9261.
13. Perret E., Benoliel A.M., Nassoy P., Pierres A., Delmas V., Thiery J.P., Bongrand P., Feracci H. Fast dissociation kinetics between individual E-cadherin fragments revealed by flow chamber analysis. EMBO J. 2002, 21:2537-2546.
14. Patel S.D., Ciatto C., Chen C.P., Bahna F., Rajebhosale M., Arkus N., Schieren I., Jessell T.M., Honig B., Price S.R., Shapiro L. Type II cadherin ectodomain structures: implications for classical cadherin specificity. Cell 2006, 124:1255-1268.
15. Jeanes A., Gottardi C.J., Yap A.S. Cadherins and cancer: how does cadherin dysfunction promote tumor progression?. Oncogene 2008, 27:6920-6929.
16. Oka H., Shiozaki H., Kobayashi K., Inoue M., Tahara H., Kobayashi T., Takatsuka Y., Matsuyoshi N., Hirano S., Takeichi M. Expression of E-cadherin cell adhesion molecules in human breast cancer tissues and its relationship to metastasis. Cancer Res. 1993, 53:1696-1701.
17. Gonzalez-Angulo A.M., Sahin A., Krishnamurthy S., Yang Y., Kau S.W., Hortobagyi G.N., Cristofanilli M. Biologic markers in axillary node-negative breast cancer: differential expression in invasive ductal carcinoma versus invasive lobular carcinoma. Clin. Breast Cancer 2006, 7:396-400.
18. Gottardi C.J., Wong E., Gumbiner B.M. E-cadherin suppresses cellular transformation by inhibiting beta-catenin signaling in an adhesion-independent manner. J. Cell Biol. 2001, 153:1049-1060.
19. Berx G., van Roy F. Involvement of members of the cadherin superfamily in cancer. Cold Spring Harb. Perspect. Biol. 2009, 1:a003129.
20. Hazan R.B., Qiao R., Keren R., Badano I., Suyama K. Cadherin switch in tumor progression. Ann. N. Y. Acad. Sci. 2004, 1014:155-163.
21. Hazan R.B., Phillips G.R., Qiao R.F., Norton L., Aaronson S.A. Exogenous expression of N-cadherin in breast cancer cells induces cell migration, invasion, and metastasis. J. Cell Biol. 2000, 148:779-790.
22. Li G., Satyamoorthy K., Herlyn M. N-cadherin-mediated intercellular interactions promote survival and migration of melanoma cells. Cancer Res. 2001, 61:3819-3825.
23. Islam S., Carey T.E., Wolf G.T., Wheelock M.J., Johnson K.R. Expression of N-cadherin by human squamous carcinoma cells induces a scattered fibroblastic phenotype with disrupted cell-cell adhesion. J. Cell Biol. 1996, 135:1643-1654.
24. Nieman M.T., Prudoff R.S., Johnson K.R., Wheelock M.J. N-cadherin promotes motility in human breast cancer cells regardless of their E-cadherin expression. J. Cell Biol. 1999, 147:631-644.
25. Okazaki M., Takeshita S., Kawai S., Kikuno R., Tsujimura A., Kudo A., Amann E. Molecular cloning and characterization of OB-cadherin, a new member of cadherin family expressed in osteoblasts. J. Biol. Chem. 1994, 269:12092-12098.
26. Hoffmann I., Balling R. Cloning and expression analysis of a novel mesodermally expressed cadherin. Dev. Biol. 1995, 169:337-346.
27. Orlandini M., Oliviero S. In fibroblasts Vegf-D expression is induced by cell-cell contact mediated by cadherin-11. J. Biol. Chem. 2001, 276:6576-6581.
28. Pishvaian M.J., Feltes C.M., Thompson P., Bussemakers M.J., Schalken J.A., Byers S.W. Cadherin-11 is expressed in invasive breast cancer cell lines. Cancer Res. 1999, 59:947-952.
29. Feltes C.M., Kudo A., Blaschuk O., Byers S.W. An alternatively spliced cadherin-11 enhances human breast cancer cell invasion. Cancer Res. 2002, 62:6688-6697.
30. Chu K., Cheng C.J., Ye X., Lee Y.C., Zurita A.J., Chen D.T., Yu-Lee L.Y., Zhang S., Yeh E.T., Hu M.C., Logothetis C.J., Lin S.H. Cadherin-11 promotes the metastasis of prostate cancer cells to bone. Mol. Cancer Res. 2008, 6:1259-1267.
31. Tomita K., van Bokhoven A., van Leenders G.J., Ruijter E.T., Jansen C.F., Bussemakers M.J., Schalken J.A. Cadherin switching in human prostate cancer progression. Cancer Res. 2000, 60:3650-3654.
32. Frank D.A. STAT3 as a central mediator of neoplastic cellular transformation. Cancer Lett. 2007, 251:199-210.
33. Yu H., Pardoll D., Jove R. STATs in cancer inflammation and immunity: a leading role for STAT3. Nat. Rev. Cancer 2009, 9:798-809.
34. Vultur A., Cao J., Arulanandam R., Turkson J., Jove R., Greer P., Craig A., Elliott B.E., Raptis L. Cell to cell adhesion modulates Stat3 activity in normal and breast carcinoma cells. Oncogene 2004, 23:2600-2616.
35. Vultur A., Arulanandam R., Turkson J., Niu G., Jove R., Raptis L. Stat3 is required for full neoplastic transformation by the Simian Virus 40 Large Tumor antigen. Mol. Biol. Cell 2005, 16:3832-3846.
36. Raptis L., Arulanandam R., Vultur A., Geletu M., Chevalier S., Feracci H. Beyond structure, to survival: Stat3 activation by cadherin engagement. Biochem. Cell Biol. 2009, 87:835-843.
37. Arulanandam R., Vultur A., Cao J., Carefoot E., Truesdell P., Elliott B., Larue L., Feracci H., Raptis L. Cadherin-cadherin engagement promotes survival via Rac/Cdc42 and Stat3. Mol. Cancer Res. 2009, 17:1310-1327.
38. Mak H., Naba A., Varma S., Schick C., Day A., SenGupta S.K., Arpin M., Elliott B.E. Ezrin phosphorylation on tyrosine 477 regulates invasion and metastasis of breast cancer cells. BMC Cancer 2012, 12:82.
39. Greer S., Honeywell R., Geletu M., Arulanandam R., Raptis L. Housekeeping gene products; levels may change with confluence of cultured cells. J. Immunol. Methods 2010, 355:76-79.
40. Narimatsu M., Maeda H., Itoh S., Atsumi T., Ohtani T., Nishida K., Itoh M., Kamimura D., Park S.J., Mizuno K., Miyazaki J., Hibi M., Ishihara K., Nakajima K., Hirano T. Tissue-specific autoregulation of the stat3 gene and its role in interleukin-6-induced survival signals in T cells. Mol. Cell. Biol. 2001, 21:6615-6625.
41. Gritsko T., Williams A., Turkson J., Kaneko S., Bowman T., Huang M., Nam S., Eweis I., Diaz N., Sullivan D., Yoder S., Enkemann S., Eschrich S., Lee J.H., Beam C.A., Cheng J., Minton S., Muro-Cacho C.A., Jove R. Persistent activation of stat3 signaling induces survivin gene expression and confers resistance to apoptosis in human breast cancer cells. Clin. Cancer Res. 2006, 12:11-19.
42. Raptis L., Arulanandam R., Geletu M., Turkson J. The R(h)oads to Stat3: Stat3 activation by the Rho GTPases. Exp. Cell Res. 2011, 317:1787-1795.
43. Lynch E.A., Stall J., Schmidt G., Chavrier P., D'Souza-Schorey C. Proteasome-mediated degradation of Rac1-GTP during epithelial cell scattering. Mol. Biol. Cell 2006, 17:2236-2242.
44. Zhu Q., Wani G., Yao J., Patnaik S., Wang Q.E., El Mahdy M.A., Praetorius-Ibba M., Wani A.A. The ubiquitin-proteasome system regulates p53-mediated transcription at p21waf1 promoter. Oncogene 2007, 26:4199-4208.
45. Chowdary D.R., Dermody J.J., Jha K.K., Ozer H.L. Accumulation of p53 in a mutant cell line defective in the ubiquitin pathway. Mol. Cell. Biol. 1994, 14:1997-2003.
46. Sulciner D.J., Irani K., Yu Z.X., Ferrans V.J., Goldschmidt-Clermont P., Finkel T. rac1 regulates a cytokine-stimulated, redox-dependent pathway necessary for NF-kappaB activation. Mol. Cell. Biol. 1996, 16:7115-7121.
47. Zhang Y., Turkson J., Carter-Su C., Smithgall T., Levitzki A., Kraker A., Krolewski J.J., Medveczky P., Jove R. Activation of Stat3 in v-Src transformed fibroblasts requires cooperation of Jak1 kinase activity. J. Biol. Chem. 2000, 275:24935-24944.
48. Fischer P., Hilfiker-Kleiner D. Survival pathways in hypertrophy and heart failure: the gp130-STAT axis. Basic Res. Cardiol. 2007, 102:393-411.
49. Fischer P., Hilfiker-Kleiner D. Role of gp130-mediated signalling pathways in the heart and its impact on potential therapeutic aspects. Br. J. Pharmacol. 2008, 153(Suppl. 1):S414-S427.
50. Grandis J.R., Drenning S.D., Zeng Q., Watkins S.C., Melhem M.F., Endo S., Johnson D.E., Huang L., He Y., Kim J.D. Constitutive activation of Stat3 signaling abrogates apoptosis in squamous cell carcinogenesis in vivo. Proc. Natl. Acad. Sci. U. S. A. 2000, 97:4227-4232.
51. Epling-Burnette P.K., Liu J.H., Catlett-Falcone R., Turkson J., Oshiro M., Kothapalli R., Li Y., Wang J.M., Yang-Yen H.F., Karras J., Jove R., Loughran T.P. Inhibition of STAT3 signaling leads to apoptosis of leukemic large granular lymphocytes and decreased Mcl-1 expression. J. Clin. Invest. 2001, 107:351-362.
52. Niu G., Wright K.L., Ma Y., Wright G.M., Huang M., Irby R., Briggs J., Karras J., Cress W.D., Pardoll D., Jove R., Chen J., Yu H. Role of Stat3 in regulating p53 expression and function. Mol. Cell. Biol. 2005, 25:7432-7440.
53. Nobes C.D., Hall A. Rho GTPases control polarity, protrusion, and adhesion during cell movement. J. Cell Biol. 1999, 144:1235-1244.
54. Geletu M., Chaize C., Arulanandam R., Vultur A., Kowolik C., Anagnostopoulou A., Jove R., Raptis L. Stat3 activity is required for gap junctional permeability in normal epithelial cells and fibroblasts. DNA Cell Biol. 2009, 28:319-327.
55. Littlefield S.L., Baird M.C., Anagnostopoulou A., Raptis L. Synthesis, characterization and Stat3 inhibitory properties of the prototypical platinum(IV) anticancer drug, [PtCl3(NO2)(NH3)2] (CPA-7). Inorg. Chem. 2008, 47:2798-2804.
56. Debidda M., Wang L., Zang H., Poli V., Zheng Y. A role of STAT3 in Rho GTPase-regulated cell migration and proliferation. J. Biol. Chem. 2005, 280:17275-17285.
57. Perrais M., Chen X., Perez-Moreno M., Gumbiner B.M. E-cadherin homophilic ligation inhibits cell growth and epidermal growth factor receptor signaling independently of other cell interactions. Mol. Biol. Cell 2007, 18:2013-2025.
58. Kiener H.P., Stipp C.S., Allen P.G., Higgins J.M., Brenner M.B. The cadherin-11 cytoplasmic juxtamembrane domain promotes alpha-catenin turnover at adherens junctions and intercellular motility. Mol. Biol. Cell 2006, 17:2366-2376.
59. Arulanandam R., Geletu M., Feracci H., Raptis L. RacV12 requires gp130 for Stat3 activation, cell proliferation and migration. Exp. Cell Res. 2010, 316:875-886.
60. Dudka A.A., Sweet S.M., Heath J.K. Signal transducers and activators of transcription-3 binding to the fibroblast growth factor receptor is activated by receptor amplification. Cancer Res. 2010, 70:3391-3401.
61. Hulit J., Suyama K., Chung S., Keren R., Agiostratidou G., Shan W., Dong X., Williams T.M., Lisanti M.P., Knudsen K., Hazan R.B. N-cadherin signaling potentiates mammary tumor metastasis via enhanced extracellular signal-regulated kinase activation. Cancer Res. 2007, 67:3106-3116.
62. Kim J.B., Islam S., Kim Y.J., Prudoff R.S., Sass K.M., Wheelock M.J., Johnson K.R. N-Cadherin extracellular repeat 4 mediates epithelial to mesenchymal transition and increased motility. J. Cell Biol. 2000, 151:1193-1206.
63. Chung S., Yao J., Suyama K., Bajaj S., Qian X., Loudig O.D., Eugenin E.A., Phillips G.R., Hazan R.B. N-cadherin regulates mammary tumor cell migration through Akt3 suppression. Oncogene 2013, 32:422-430.
64. Boscher C., Mege R.M. Cadherin-11 interacts with the FGF receptor and induces neurite outgrowth through associated downstream signalling. Cell. Signal. 2008, 20:1061-1072.
65. Lazo J.S., Nemoto K., Pestell K.E., Cooley K., Southwick E.C., Mitchell D.A., Furey W., Gussio R., Zaharevitz D.W., Joo B., Wipf P. Identification of a potent and selective pharmacophore for Cdc25 dual specificity phosphatase inhibitors. Mol. Pharmacol. 2002, 61:720-728.
66. Raptis L., Brownell H.L., Vultur A.M., Ross G., Tremblay E., Elliott B.E. Specific inhibition of growth factor-stimulated ERK1/2 activation in intact cells by electroporation of a Grb2-SH2 binding peptide. Cell Growth Differ. 2000, 11:293-303.
67. Anagnostopoulou A., Vultur A., Arulanandam R., Cao J., Turkson J., Jove R., Kim J.S., Glenn M., Hamilton A.D., Raptis L. Differential effects of Stat3 inhibition in sparse vs confluent normal and breast cancer cells. Cancer Lett. 2006, 242:120-132.
68. Murga C., Zohar M., Teramoto H., Gutkind J.S. Rac1 and RhoG promote cell survival by the activation of PI3K and Akt, independently of their ability to stimulate JNK and NF-kappaB. Oncogene 2002, 21:207-216.